Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q5383774> ?p ?o }
Showing triples 1 to 49 of
49
with 100 triples per page.
- Q5383774 subject Q7139608.
- Q5383774 subject Q8529670.
- Q5383774 subject Q8878420.
- Q5383774 subject Q9052323.
- Q5383774 subject Q9062082.
- Q5383774 abstract "Eplivanserin (SR-46,349; planned trade name Ciltyri) was an experimental drug for the treatment of insomnia which was being developed by Sanofi Aventis.Sanofi Aventis announced in December 2009 that it was withdrawing its application for approval of eplivanserin from both the U.S. Food and Drug Administration and the European Medicines Agency.".
- Q5383774 atcPrefix "none".
- Q5383774 casNumber "130579-75-8".
- Q5383774 casSupplemental "(fumarate)".
- Q5383774 fdaUniiCode "3CO94WO6DJ".
- Q5383774 iupacName "(Z,E)-1-(2-fluorophenyl)-3-(4-hydroxyphenyl)-2-propen-1-one O-[2-(dimethylamino)ethyl]oxime".
- Q5383774 pubchem "5493160".
- Q5383774 thumbnail Eplivanserin_structure.svg?width=300.
- Q5383774 wikiPageWikiLink Q130146.
- Q5383774 wikiPageWikiLink Q139857.
- Q5383774 wikiPageWikiLink Q14891424.
- Q5383774 wikiPageWikiLink Q158205.
- Q5383774 wikiPageWikiLink Q1671731.
- Q5383774 wikiPageWikiLink Q1869874.
- Q5383774 wikiPageWikiLink Q204711.
- Q5383774 wikiPageWikiLink Q221361.
- Q5383774 wikiPageWikiLink Q238516.
- Q5383774 wikiPageWikiLink Q410568.
- Q5383774 wikiPageWikiLink Q412443.
- Q5383774 wikiPageWikiLink Q415496.
- Q5383774 wikiPageWikiLink Q421930.
- Q5383774 wikiPageWikiLink Q424228.
- Q5383774 wikiPageWikiLink Q574801.
- Q5383774 wikiPageWikiLink Q7139608.
- Q5383774 wikiPageWikiLink Q7180990.
- Q5383774 wikiPageWikiLink Q7194603.
- Q5383774 wikiPageWikiLink Q7940202.
- Q5383774 wikiPageWikiLink Q8529670.
- Q5383774 wikiPageWikiLink Q8878420.
- Q5383774 wikiPageWikiLink Q9052323.
- Q5383774 wikiPageWikiLink Q9062082.
- Q5383774 atcPrefix "none".
- Q5383774 casNumber "130579".
- Q5383774 iupacName "-1".
- Q5383774 pubchem "5493160".
- Q5383774 unii "3".
- Q5383774 type ChemicalSubstance.
- Q5383774 type Drug.
- Q5383774 type ChemicalObject.
- Q5383774 type Thing.
- Q5383774 type Q8386.
- Q5383774 comment "Eplivanserin (SR-46,349; planned trade name Ciltyri) was an experimental drug for the treatment of insomnia which was being developed by Sanofi Aventis.Sanofi Aventis announced in December 2009 that it was withdrawing its application for approval of eplivanserin from both the U.S. Food and Drug Administration and the European Medicines Agency.".
- Q5383774 label "Eplivanserin".
- Q5383774 depiction Eplivanserin_structure.svg.